Memantine Hydrochloride
Memantine Hydrochloride is a pharmaceutical drug with 21 clinical trials. Currently 3 active trials ongoing. Historical success rate of 81.8%.
Success Metrics
Based on 9 completed trials
Phase Distribution
Phase Distribution
4
Early Stage
6
Mid Stage
7
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
75.0%
9 of 12 finished
25.0%
3 ended early
3
trials recruiting
21
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippocampus is Better at Preventing Loss of Memory and Thinking Ability
Targeting Spreading Depolarization After Chronic Subdural Hematoma Surgery (TASD)
Memantine for the Treatment of Social Deficits in Youth With Disorders of Impaired Social Interactions
Ultrasound-Guided Stellate Ganglion Block for Alzheimer's Disease
A Study to See if Memantine Protects the Brain During Radiation Therapy Treatment for a Brain Tumor
Clinical Trials (21)
Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippocampus is Better at Preventing Loss of Memory and Thinking Ability
Targeting Spreading Depolarization After Chronic Subdural Hematoma Surgery (TASD)
Memantine for the Treatment of Social Deficits in Youth With Disorders of Impaired Social Interactions
Ultrasound-Guided Stellate Ganglion Block for Alzheimer's Disease
A Study to See if Memantine Protects the Brain During Radiation Therapy Treatment for a Brain Tumor
Memantine Hydrochloride in Prostate Cancer Patients
The Study of Atezolizumab, Bevacizumab and Memantine in Patients With Hepatocellular Carcinoma (HCC)
Temozolomide, Memantine Hydrochloride, Mefloquine, and Metformin Hydrochloride in Treating Patients With Glioblastoma Multiforme After Radiation Therapy
Memantine for the Reduction of Cognitive Impairment After Radiation Therapy in Pediatric Patients With Central Nervous System Tumors
Memantine Hydrochloride for Treatment of Cognitive Dysfunction Due to Traumatic Brain Injury
Effect of Early Memantine Administration on Outcome of Patients With Moderate to Severe Traumatic Brain Injury
Memantine Hydrochloride in Helping Cancer Survivors Stop Smoking
Neurocognitive Outcome of Bilateral or Unilateral Hippocampal Avoidance WBRT With Memantine for Brain Metastases
Effect of Memantine on Cognitive Impairment in Patients With Epilepsy
A Phase - IIa - IIb, Trial to Study the Safety, Tolerability and Efficacy of Memantine as a Long-term Treatment of SCD
Memantine Treatment in Alzheimer's Disease Patients
Memantine for Executive Dysfunction in Adults With ADHD: A Pilot Study
Memantine Treatment Study of Pathological Gambling
Open-Label Pilot Study of Namenda in Adult Subjects With ADHD and ADHD NOS
Open Label Pilot Study of the Effects of Memantine on FDG-PET in Frontotemporal Dementia
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 21